{
    "Trade/Device Name(s)": [
        "UCP Home Drug Screening Test Card",
        "UCP Home Drug Screening Test Cup",
        "UCP Home Drug Screening Test Cards",
        "UCP Home Drug Screening Test Cups"
    ],
    "Submitter Information": "UCP Biosciences, Inc.",
    "510(k) Number": "K091588",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050540",
        "K061457",
        "K072062"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "LAF",
        "DIO",
        "DIS",
        "JXM",
        "DJC",
        "DMB",
        "DJG",
        "LCM",
        "LDJ",
        "LFG"
    ],
    "Summary Letter Date": "August 13, 2009",
    "Summary Letter Received Date": "August 13, 2009",
    "Submission Date": "May 28, 2009",
    "Regulation Number(s)": [
        "21CFR862.3650",
        "21CFR862.3100",
        "21CFR862.3250",
        "21CFR862.3150",
        "21CFR862.3610",
        "21CFR862.3620",
        "21CFR862.3870",
        "21CFR862.3910"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Methamphetamine",
        "Cocaine",
        "Barbiturates",
        "Benzodiazepines",
        "MDMA",
        "Opiates",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Cannabinoids (Marijuana)",
        "Tricyclic Antidepressants",
        "Morphine",
        "Secobarbital",
        "Oxazepam",
        "Benzoylecgonine",
        "Delta-9-THC-COOH",
        "Nortriptyline"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunoassay",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative drug detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Cup",
        "Card",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for UCP Home Drug Screening Test Card and Cup, lateral flow immunochromatographic OTC urine drug screening assays for multiple drugs of abuse.",
    "Indications for Use Summary": "For rapid, qualitative, competitive binding immunoassay detection of multiple drugs of abuse and their metabolites in human urine, intended for OTC and prescription use as a preliminary screen; results are for initial information and require laboratory confirmation.",
    "fda_folder": "Toxicology"
}